For: | Rubie C, Frick VO, Wagner M, Weber C, Kruse B, Kempf K, König J, Rau B, Schilling M. Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases. World J Gastroenterol 2006; 12(41): 6627-6633 [PMID: PMC4125667 DOI: 10.3748/wjg.v12.i41.6627] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i41/6627.htm |
Number | Citing Articles |
1 |
Morgan O'Hayre, Catherina L. Salanga, Tracy M. Handel, Samantha J. Allen. Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment. Biochemical Journal 2008; 409(3): 635 doi: 10.1042/BJ20071493
|
2 |
Alexander Pedroza-Gonzalez, Cornelis Verhoef, Jan N. M. Ijzermans, Maikel P. Peppelenbosch, Jaap Kwekkeboom, Joanne Verheij, Harry L. A. Janssen, Dave Sprengers. Activated tumor-infiltrating CD4+ regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancer. Hepatology 2013; 57(1): 183 doi: 10.1002/hep.26013
|
3 |
V. O. Frick, C. .Rubie, K. Kölsch, M. Wagner, P. Ghadjar, S. Graeber, M. Glanemann. CCR6/CCL20 Chemokine Expression Profile in Distinct Colorectal Malignancies. Scandinavian Journal of Immunology 2013; 78(3): 298 doi: 10.1111/sji.12087
|
4 |
Rosa Mistica C. Ignacio, Syeda M. Kabir, Eun-Sook Lee, Samuel E. Adunyah, Deok-Soo Son, Jung Weon Lee. NF-κB-Mediated CCL20 Reigns Dominantly in CXCR2-Driven Ovarian Cancer Progression. PLOS ONE 2016; 11(10): e0164189 doi: 10.1371/journal.pone.0164189
|
5 |
Xiaolei Jiao, Guiming Shu, Hui Liu, Qin Zhang, Zhe Ma, Chaoyi Ren, Hongsheng Guo, Jingxiang Shi, Junguo Liu, Chuanshan Zhang, Yijun Wang, Yingtang Gao. The Diagnostic Value of Chemokine/Chemokine Receptor Pairs in Hepatocellular Carcinoma and Colorectal Liver Metastasis. Journal of Histochemistry & Cytochemistry 2019; 67(5): 299 doi: 10.1369/0022155418824274
|
6 |
Mathias Wagner, Benjamin Vicinus, Sherieda T. Muthra, Tereza A. Richards, Roland Linder, Vilma Oliveira Frick, Andreas Groh, Claudia Rubie, Frank Weichert. Text mining, a race against time? An attempt to quantify possible variations in text corpora of medical publications throughout the years. Computers in Biology and Medicine 2016; 73: 173 doi: 10.1016/j.compbiomed.2016.03.016
|
7 |
YONG BEOM CHO, WOO YONG LEE, SO-JUNG CHOI, JHINGOOK KIM, HYE KYUNG HONG, SEOK-HYUNG KIM, YOON-LA CHOI, HEE CHEOL KIM, SEONG HYEON YUN, HO-KYUNG CHUN, KUHN UK LEE. CC chemokine ligand 7 expression in liver metastasis of colorectal cancer. Oncology Reports 2012; 28(2): 689 doi: 10.3892/or.2012.1815
|
8 |
Alessandro Carrer, Serena Zacchigna, Alessandro Balani, Valentina Pistan, Adelino Adami, Fabio Porcelli, Monica Scaramucci, Mauro Roseano, Angelo Turoldo, Maria Cristina Prati, Matteo Dell’Omodarme, Nicolo’ de Manzini, Mauro Giacca. Expression profiling of angiogenic genes for the characterisation of colorectal carcinoma. European Journal of Cancer 2008; 44(12): 1761 doi: 10.1016/j.ejca.2008.05.014
|
9 |
Xiangjiu Ding, Kexin Wang, Hui Wang, Guangyong Zhang, Yajing Liu, Qingyun Yang, Weijie Chen, Sanyuan Hu. High Expression of CCL20 Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma after Curative Resection. Journal of Gastrointestinal Surgery 2012; 16(4): 828 doi: 10.1007/s11605-011-1775-4
|
10 |
Noe Rico Montanari, Chimaobi M. Anugwom, Andre Boonstra, Jose D. Debes. The Role of Cytokines in the Different Stages of Hepatocellular Carcinoma. Cancers 2021; 13(19): 4876 doi: 10.3390/cancers13194876
|
11 |
C. Rubie, V. Oliveira Frick, M. Wagner, M. K. Schilling. Chirurgisches Forum und DGAV Forum 2009. Deutsche Gesellschaft für Chirurgie 2009; 38: 43 doi: 10.1007/978-3-642-00625-8_18
|
12 |
Vilma Oliveira Frick, Claudia Rubie, Pirus Ghadjar, Sabrina K. Faust, Mathias Wagner, Stefan Gräber, Martin K. Schilling. Changes in CXCL12/CXCR4-chemokine expression during onset of colorectal malignancies. Tumor Biology 2011; 32(1): 189 doi: 10.1007/s13277-010-0112-y
|
13 |
Liang Wang, Huaizhou Qin, Lihong Li, Yongsheng Zhang, Yanyang TU, Fuqiang Feng, Peigang Ji, Jingyu Zhang, Gang Li, Zhenwei Zhao, Guodong Gao. Overexpression of CCL20 and its receptor CCR6 predicts poor clinical prognosis in human gliomas. Medical Oncology 2012; 29(5): 3491 doi: 10.1007/s12032-012-0314-9
|
14 |
Jiamin Zhou, Yi Xiang, Teizo Yoshimura, Keqiang Chen, Wanghua Gong, Jian Huang, Ye Zhou, Xiaohong Yao, Xiuwu Bian, Ji Ming Wang. The Role of Chemoattractant Receptors in Shaping the Tumor Microenvironment. BioMed Research International 2014; 2014: 1 doi: 10.1155/2014/751392
|
15 |
Frank Simon, Maximilian Bockhorn, Christian Praha, Hideo A. Baba, Christoph E. Broelsch, Andrea Frilling, Frank Weber. Deregulation of HIF1-alpha and hypoxia-regulated pathways in hepatocellular carcinoma and corresponding non-malignant liver tissue—influence of a modulated host stroma on the prognosis of HCC. Langenbeck's Archives of Surgery 2010; 395(4): 395 doi: 10.1007/s00423-009-0590-9
|
16 |
C. Rubie, O. Kollmar, V. O. Frick, M. Wagner, B. Brittner, S. Gräber, M. K. Schilling. Differential CXC Receptor Expression in Colorectal Carcinomas. Scandinavian Journal of Immunology 2008; 68(6): 635 doi: 10.1111/j.1365-3083.2008.02163.x
|
17 |
Wen-Ting Liu, Ying-Ying Jing, Fei Yan, Zhi-Peng Han, Fo-Bao Lai, Jian-Xing Zeng, Guo-Feng Yu, Qing-Min Fan, Rong Li, Qiu-Dong Zhao, Meng-Chao Wu, Li-Xin Wei. LPS-induced CXCR4-dependent migratory properties and a mesenchymal-like phenotype of colorectal cancer cells. Cell Adhesion & Migration 2017; 11(1): 13 doi: 10.1080/19336918.2015.1134404
|
18 |
Deepa S Mandlik, Satish K Mandlik, Heena B Choudhary. Immunotherapy for hepatocellular carcinoma: Current status and future perspectives. World Journal of Gastroenterology 2023; 29(6): 1054-1075 doi: 10.3748/wjg.v29.i6.1054
|
19 |
Hui Dong, Xijin Ge, Yan Shen, Linlei Chen, Yalin Kong, Hongyi Zhang, Xiaobo Man, Liang Tang, Hong Yuan, Hongyang Wang, Guoping Zhao, Weirong Jin. Gene expression profile analysis of human hepatocellular carcinoma using SAGE and LongSAGE. BMC Medical Genomics 2009; 2(1) doi: 10.1186/1755-8794-2-5
|
20 |
Sulemon Chaudhry, Jean Emond, Adam Griesemer. Immune Cell Trafficking to the Liver. Transplantation 2019; 103(7): 1323 doi: 10.1097/TP.0000000000002690
|
21 |
Bianca C. Dobner, Aline I. Riechardt, Antonia M. Joussen, Stefan Englert, Nikolaos E. Bechrakis. Expression of haematogenous and lymphogenous chemokine receptors and their ligands on uveal melanoma in association with liver metastasis. Acta Ophthalmologica 2012; 90(8) doi: 10.1111/j.1755-3768.2012.02515.x
|
22 |
Meenakshi Sachdeva, Yogesh K Chawla, Sunil K Arora. Immunology of hepatocellular carcinoma. World Journal of Hepatology 2015; 7(17): 2080-2090 doi: 10.4254/wjh.v7.i17.2080
|
23 |
Mie A. Mohamed, Azza Abdel-Aziz. Evaluation of CXCR4 chemokine receptor as a prognostic marker in colorectal carcinoma. Egyptian Journal of Pathology 2011; 31(1): 19 doi: 10.1097/01.XEJ.0000398107.88640.db
|
24 |
Saskia Trescher, Jannes Münchmeyer, Ulf Leser. Estimating genome-wide regulatory activity from multi-omics data sets using mathematical optimization. BMC Systems Biology 2017; 11(1) doi: 10.1186/s12918-017-0419-z
|
25 |
Yoshihiro Minamiya, Hajime Saito, Naoko Takahashi, Manabu Ito, Hiroshi Toda, Takashi Ono, Hayato Konno, Satoru Motoyama, Jun-ichi Ogawa. Expression of the chemokine receptor CCR6 correlates with a favorable prognosis in patients with adenocarcinoma of the lung. Tumor Biology 2011; 32(1): 197 doi: 10.1007/s13277-010-0113-x
|
26 |
Otto Kollmar, Michael D. Menger, Martin K. Schilling. Liver Metastasis: Biology and Clinical Management. Cancer Metastasis - Biology and Treatment 2011; 16: 129 doi: 10.1007/978-94-007-0292-9_5
|
27 |
Burcu Saka, Ozgur Ekinci, Ayse Dursun, Nalan Akyurek. Clinicopathologic and prognostic significance of immunohistochemical expression of HIF-1α, CXCR4 and CA9 in colorectal carcinoma. Pathology - Research and Practice 2017; 213(7): 783 doi: 10.1016/j.prp.2017.04.001
|
28 |
M. Wahl, R. Guenther, L. Yang, A. Bergman, U. Straehle, S. Strack, C. Weiss. Polybrominated diphenyl ethers and arylhydrocarbon receptor agonists: Different toxicity and target gene expression. Toxicology Letters 2010; 198(2): 119 doi: 10.1016/j.toxlet.2010.06.001
|
29 |
DAN CHEN, KAI YANG, GUODONG ZHANG, JIE MEI, LI XIANG. Screen and analysis of key disease genes for precancerous lesions of oral buccal mucosa induced by DMBA in golden hamsters. Oncology Letters 2011; 2(2): 265 doi: 10.3892/ol.2010.228
|
30 |
Daniel Kaemmerer, Robin Schindler, Franziska Mußbach, Uta Dahmen, Annelore Altendorf-Hofmann, Olaf Dirsch, Jörg Sänger, Stefan Schulz, Amelie Lupp. Somatostatin and CXCR4 chemokine receptor expression in hepatocellular and cholangiocellular carcinomas: tumor capillaries as promising targets. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3911-3
|
31 |
Claudia Rubie, Vilma O Frick, Pirus Ghadjar, Mathias Wagner, Christoph Justinger, Sabrina K Faust, Benjamin Vicinus, Stefan Gräber, Otto Kollmar, Martin K Schilling. CXC receptor-4 mRNA silencing abrogates CXCL12-induced migration of colorectal cancer cells. Journal of Translational Medicine 2011; 9(1) doi: 10.1186/1479-5876-9-22
|
32 |
Xiongfeng Pan, Atipatsa C Kaminga, Shi Wu Wen, Aizhong Liu. Chemokines in hepatocellular carcinoma: a meta-analysis. Carcinogenesis 2020; 41(12): 1682 doi: 10.1093/carcin/bgaa106
|